Boston Scientific Corporation (NYSE:BSX) provides specialized products and services for the medical industry. Its products and services are used within the cardiovascular, radiology, oncology, urology and gynecology medical fields.

Boston Scientific started to produce revenue growth in recent years but it has a history earnings losses. For the first time in a decade the company reported a solid profit for the 2018 fiscal year. Boston Scientific has gone on an acquisition spree acquiring medical based businesses that will complement and expand its products and services. The company is in fairly good financial shape with well-contained debt levels.

The company's management is optimistic about the company's future which is supported by the majority of analysts covering the stock. I consider the stock somewhat speculative as it does not have a proven earnings growth history. Its future earnings performance is based on its one good 2018 year being replicated in future years. I think this is certainly possible and if the company succeeds its stock price could really surge higher.

READ FULL ARTICLE HERE